COVID-19 Therapeutics for Nonhospitalized Older Adults
This Viewpoint summarizes the factors contributing to increased risk of severe outcomes and hospitalization associated with COVID-19 among older adults, stresses the importance of assessing COVID-19 risk before infection occurs, calls for all immunocompromised older adults to be considered for COVID-19 treatment, and details 3 recommended COVID-19 therapies.
Authors
- Pragna Patel (ORCID: https://orcid.org/0000-0003-1386-8194)
- Demetre Daskalakis (ORCID: https://orcid.org/0000-0002-9770-0155)
- David E. Wentworth (ORCID: https://orcid.org/0000-0002-5190-980X)
Institutions
- Centers for Disease Control and Prevention (US)
- National Center for Immunization and Respiratory Diseases (US)
Publication Details
- Journal
- JAMA
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1001/jama.2024.16460
- Citations
- 2
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.78